The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...
In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...
The U.S. Food and Drug Administration wants to put nutrition information front and center on food products to give consumers ...
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug ...
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
Several years ago, a little-known drug named Ozempic — previously used only to treat diabetes — emerged as a promising new ...
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
Dr. Dorothy Fink, the acting secretary for the Department of Health and Human Services under President Donald Trump, has ...
Food additives have been a huge topic in the U.S. for years, but really caught fire earlier this month when the U.S. Food and ...